- Home
- BRLS vs RAPT Comparison
BRLS vs RAPT Comparison
Compare BRLS & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRLS
- RAPT
- Stock Information
- Founded
- BRLS 2019
- RAPT 2015
- Country
- BRLS Canada
- RAPT United States
- Employees
- BRLS N/A
- RAPT N/A
- Industry
- BRLS
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- BRLS
- RAPT Health Care
- Exchange
- BRLS NYSE
- RAPT Nasdaq
- Market Cap
- BRLS 130.4M
- RAPT 117.5M
- IPO Year
- BRLS N/A
- RAPT 2019
- Fundamental
- Price
- BRLS $3.50
- RAPT $0.89
- Analyst Decision
- BRLS
- RAPT Buy
- Analyst Count
- BRLS 0
- RAPT 5
- Target Price
- BRLS N/A
- RAPT $5.25
- AVG Volume (30 Days)
- BRLS 18.2K
- RAPT 1.1M
- Earning Date
- BRLS 05-20-2025
- RAPT 05-08-2025
- Dividend Yield
- BRLS N/A
- RAPT N/A
- EPS Growth
- BRLS N/A
- RAPT N/A
- EPS
- BRLS N/A
- RAPT N/A
- Revenue
- BRLS $26,619,131.00
- RAPT N/A
- Revenue This Year
- BRLS N/A
- RAPT N/A
- Revenue Next Year
- BRLS N/A
- RAPT N/A
- P/E Ratio
- BRLS N/A
- RAPT N/A
- Revenue Growth
- BRLS N/A
- RAPT N/A
- 52 Week Low
- BRLS $3.00
- RAPT $0.71
- 52 Week High
- BRLS $9.50
- RAPT $4.60
- Technical
- Relative Strength Index (RSI)
- BRLS 22.12
- RAPT 48.13
- Support Level
- BRLS $3.00
- RAPT $0.81
- Resistance Level
- BRLS $6.10
- RAPT $1.27
- Average True Range (ATR)
- BRLS 0.34
- RAPT 0.14
- MACD
- BRLS -0.25
- RAPT 0.01
- Stochastic Oscillator
- BRLS 16.13
- RAPT 31.55
About BRLS BOREALIS FOODS INC
Borealis Foods Inc is a food technology company that has developed high-quality, affordable, sustainable, and nutritious ready-to-eat meals. It is a mission-driven company committed to utilizing its products to help solve national and global food security and nutrition challenges. Its commitment to nutrition, affordability, and sustainability reflects its goal of positively impacting both human life and the planet. Through the development and launch of its ready-made ramen, featuring 20 grams of complete plant-based protein per serving, Borealis is developing advanced solutions to address global food challenges.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.